natgillin/translations-raw huggingface dataset:
Inner needle cap Paper tab
notranji pokrovček igle papirna nalepka
Inner needle cap Paper tab
papirna nalepka
Inner Needle Shield
Notranja zaščita igle
Inner Needle Shield
Notranje varovalo igle
Inner Needle Shield
Notranji pokrovč ek igle
inner needle shield
notranji ščitnik igle
InnoLet delivers 1-50 units in increments of 1 unit.
Injekcijski peresnik InnoLet omogoča aplikacijo od 1 do 50 enot v korakih po 1 enoto.
Innovation House, 70 Norden Road, Maidenhead, Berkshire, SL6 4AY United Kingdom
Innovation House, 70 Norden Road, Maidenhead, Berkshire, SL6 4AY Velika Britanija
Innovax-ILT is a veterinary vaccine used to protect chickens against infectious laryngotracheitis (ILT) and Marek’s disease (MD).
Innovax-ILT je cepivo za uporabo v veterinarski medicini, ki se uporablja za zaščito piščancev pred infekcijskim laringotraheitisom (ILT) in Marekovo boleznijo (MB).
Innovax-ILT suspension and solvent for suspension for injection for chickens
Innovax-ILT suspenzija in topilo za suspenzijo za injiciranje za piščance
Innovax-ILT, suspension and solvent for suspension for injection for chickens
Innovax-ILT, suspenzija in vehikel za suspenzijo za injiciranje za piščance
INOmax 400 ppm mol/mol inhalation gas
INOmax 400 ppm mol/mol plin za inhaliranje
INOmax 400 ppm mol/mol inhalation gas Nitric oxide
Zdravilo INOmax INOmax 400 ppm mol/mol plin za inhaliranje dušikov oksid
INOmax 400 ppm mol/mol inhalation gas Nitric oxide.
INOmax 400 ppm mol/mol plin za inhaliranje dušikov oksid
INOmax 800 ppm mol/mol inhalation gas
INOmax 800 ppm mol/mol plin za inhaliranje
INOmax 800 ppm mol/mol inhalation gas Nitric oxide.
INOmax 800 ppm mol/mol plin za inhaliranje dušikov oksid
INOmax contains nitric oxide, a gas used for the treatment of newborn babies with lung failure associated with high blood pressure in the lungs, a condition known as hypoxic respiratory failure.
Zdravilo INOmax vsebuje dušikov oksid, plin, ki se uporablja za zdravljenje: novorojenčkov s pljučno odpovedjo, povezano z visokim tlakom v pljučih, stanje, ki ga poznamo kot hipoksično respiratorno odpoved.
INOmax cylinders should be stored secured in order to avoid falling and thus potentially causing harm.
Jeklenke INOmax je treba shranjevati varno, tako da ne morejo pasti in povzročiti škode.
INOmax is used in combination with artificial ventilation and other medicines to help improve blood oxygen levels in the following groups of patients: newborn babies (born after 34 weeks of gestation) with breathing problems associated with pulmonary hypertension (high blood pressure in the lungs).
Zdravilo INOmax se uporablja v kombinaciji z umetnim predihavanjem in drugimi zdravili za izboljšanje koncentracije kisika v krvi pri naslednjih skupinah bolnikov: novorojenčkih (rojeni po 34. tednu nosečnosti) s težavami pri dihanju zaradi pljučne hipertenzije (visok krvni tlak v pljučih).
INOmax is used in these babies to improve oxygen supply levels and to reduce the need for extracorporeal membrane oxygenation (ECMO, a technique to oxygenate the blood outside the body using a device similar to a heart-lung machine). patients of all ages who are undergoing or have undergone heart surgery and develop pulmonary hypertension.
Zdravilo INOmax se pri teh dojenčkih uporablja za izboljšanje koncentracije kisika in zmanjšanje potrebe po zunajtelesni membranski oksigenaciji (ECMO, tehnika za oksigenizacijo krvi zunaj telesa z uporabo naprave, podobne aparatu srce-pljuča); bolnikih vseh starosti, pri katerih bo ali je bil opravljen kirurški poseg na srcu in pri katerih se je pojavila pljučna hipertenzija.
INOmax should be administered under close monitoring of haemodynamics and oxygenation.
Pri uporabi zdravila INOmax je treba skrbno spremljati hemodinamiko in oksigenacijo.
INOmax should be used and administered only by personnel specially trained in the use and handling of INOmax.
Zdravilo INOmax sme uporabljati in dajati bolnikom samo osebje, ki je posebej usposobljeno za uporabo tega zdravila in ravnanje z njim.
INOmax should be used only after conservative support has been optimised.
Zdravilo INOmax se lahko uporablja šele po optimizaciji konservativne podpore.
INOmax should only be delivered according to a neonatologist’s prescription.
Zdravilo INOmax se sme dovajati le, če ga predpiše neonatolog.
INOmax should only be delivered according to an anaesthetist’s or intensive care physician’s prescription.
Zdravilo INOmax se lahko dovaja samo, če ga predpiše anestezist ali zdravnik z intenzivne nege.
INOmax, in conjunction with ventilatory support and other appropriate active substances, is indicated:
Zdravilo INOmax je, skupaj s podporo dihanju in drugimi ustreznimi zdravilnimi učinkovinami, namenjeno:
Inoperable patient population
Populacija neoperabilnih bolnikov
Inovelon (rufinamide tablets) was administered in a double blind, placebo-controlled study, at doses of up to 45 mg/kg/day for 84 days, to 139 patients with inadequately controlled seizures associated with Lennox-Gastaut Syndrome (including both atypical absence seizures and drop attacks).
Zdravilo Inovelon (tablete rufinamida) so dajali v dvojno slepi, s placebom kontrolirani študiji v odmerkih do 45 mg/kg/dan 84 dni 139 bolnikom z nezadostno kontroliranimi epileptičnimi napadi (tako z napadi atipičnih absenc kot drop atakami), povezanimi z Lennox-Gastautovim sindromom.
Inovelon 100 mg film-coated tablets
Inovelon 100 mg filmsko obložene tablete
Inovelon 100 mg film-coated tablets Rufinamide
Inovelon 100 mg filmsko obložene tablete rufinamid
Inovelon 100 mg tablets are pink, oval, slightly convex film-coated tablets, scored on both sides, embossed ‘Є261’ on one side and blank on the other side.
Inovelon 100 mg tablete so rožnate, ovalne, rahlo konveksne filmsko obložene tablete, z zarezo na obeh straneh, z vtisnjenim napisom ‘Є261’ na eni strani in brez napisa na drugi strani.
Inovelon 200 mg film-coated tablets
Inovelon 200 mg filmsko obložene tablete
Inovelon 200 mg film-coated tablets Rufinamide
Inovelon 200 mg filmsko obložene tablete rufinamid
Inovelon 200 mg tablets are pink, oval, slightly convex film-coated tablets, scored on both sides, embossed ‘Є262’ on one side and blank on the other side.
Inovelon 200 mg tablete so rožnate, ovalne, rahlo konveksne filmsko obložene tablete, z zarezo na obeh straneh, z vtisnjenim napisom ‘Є262’ na eni strani in brez napisa na drugi strani.
Inovelon 40 mg/ml oral suspension
Inovelon 40 mg/ml peroralna suspenzija
Inovelon 400 mg film-coated tablets
Inovelon 400 mg filmsko obložene tablete
Inovelon 400 mg film-coated tablets Rufinamide
Inovelon 400 mg filmsko obložene tablete rufinamid
Inovelon 400 mg tablets are pink, oval, slightly convex film-coated tablets, scored on both sides, embossed ‘Є263’ on one side and blank on the other side.
Inovelon 400 mg tablete so rožnate, ovalne, rahlo konveksne filmsko obložene tablete, z zarezo na obeh straneh, z vtisnjenim napisom ‘Є263’ na eni strani in brez napisa na drugi strani.
Inovelon caused a reduction in the number and severity of seizures.
Zdravilo Inovelon je povzročilo zmanjšanje števila in resnosti napadov.
Inovelon contains lactose
Zdravilo Inovelon vsebuje laktozo.
Inovelon contains methyl parahydroxybenzoate (E218) and propyl parahydroxybenzoate (E216)
Zdravilo Inovelon vsebuje metilparahidroksibenzoat (E218) in propilparahidroksibenzoat (E216).
Inovelon is a medicine containing the active substance rufinamide.
Inovelon je zdravilo, ki vsebuje zdravilno učinkovino rufinamid.
Inovelon is a white slightly viscous suspension.
Zdravilo Inovelon je bela, nekoliko viskozna suspenzija.
Inovelon is indicated as adjunctive therapy in the treatment of seizures associated with Lennox-Gastaut syndrome in patients 4 years of age and older.
Zdravilo Inovelon je indicirano kot pomožno zdravilo pri zdravljenju epileptičnih napadov, povezanih z Lennox-Gastautovim sindromom pri bolnikih, starih 4 leta ali starejših.
Inovelon is indicated as adjunctive therapy in the treatment of seizures associated with Lennox-Gastaut syndrome in patients 4 years of age and older.
Zdravilo Inovelon je indicirano kot pomožno zdravilo pri zdravljenju epileptičnih napadov, povezanih z Lennox-Gastautovim sindromom, pri bolnikih, starih 4 leta in starejših.
Inovelon is used as an add-on to other anti-epileptic medicines.
Zdravilo Inovelon se uporablja kot dodatno zdravilo pri zdravljenju z drugimi zdravili proti epilepsiji.
Inovelon is used to treat patients aged four years or older who have Lennox-Gastaut syndrome, a rare type of epilepsy that usually affects children but which can continue into adulthood.
Zdravilo Inovelon se uporablja pri zdravljenju bolnikov, starih štiri leta ali več, z Lennox-Gastautovim sindromom, redko obliko epilepsije, ki navadno prizadene otroke, a se lahko nadaljuje tudi v odraslem obdobju.
Inovelon is used with other medicines to treat seizures associated with Lennox-Gastaut syndrome in adults, adolescents and children over 4 years of age.
Zdravilo Inovelon se uporablja z drugimi zdravili za zdravljenje epileptičnih napadov, povezanih z Lennox-Gastautovim sindromom pri odraslih, mladostnikih in otrocih, starih več kot 4 leta.
Inovelon may cause dizziness, somnolence and blurred vision.
Zdravilo Inovelon lahko povzroči vrtoglavost, zaspanost in zamegljen vid.
Inovelon may make hormonal/oral contraceptives such as the contraceptive pill less effective.
Zdravilo Inovelon lahko zmanjša učinkovitost hormonskih/peroralnih kontraceptivov kot so »kontracepcijske tabletke«.
Inovelon may make hormonal/oral contraceptives such as the contraceptive pill less effective.
Zdravilo Inovelon lahko zmanjša učinkovitost hormonskih/peroralnih kontraceptivov, kot so »kontracepcijske tabletke«.
Inovelon may make you feel dizzy, drowsy and affect your vision, particularly at the beginning of treatment or after a dose increase.
Zdravilo Inovelon lahko povzroči omotičnost, zaspanost in zamegljen vid, zlasti na začetku zdravljenja ali po povečanju odmerka.
Inovelon must be taken twice every day, once in the morning and once in the evening.
Zdravilo Inovelon morate jemati dvakrat na dan, zjutraj in zvečer.
Inovelon oral suspension and Inovelon film coated tablets have been demonstrated to be bioequivalent.
Dokazano je bilo, da sta zdravilo Inovelon peroralna suspenzija in zdravilo Inovelon filmsko obložene tablete bioekvivalentna.
Inovelon oral suspension and Inovelon film coated tablets may be interchanged at equal doses.
Zdravilo Inovelon peroralna suspenzija in zdravilo Inovelon filmsko obložene tablete sta v enakih odmerkih zamenljiva.
Inovelon should be taken with food.
Zdravilo Inovelon morate jemati s hrano.
Inovelon should be taken with water and food twice a day.
Zdravilo Inovelon je treba zaužiti skupaj z vodo in hrano dvakrat na dan.
Inovelon should not be given to children younger than 4 years of age since there is not enough information on its use in this age group.
Otroci, mlajši od 4 let, ne smejo dobivati zdravila Inovelon, saj ni dovolj informacij za uporabo v tej starostni skupini.
Inovelon should not be used in patients who have severe problems with their liver.
Zdravila Inovelon ne smejo jemati bolniki s hudimi težavami z jetri.
INPULSIS-1 and INPULSIS-2
INPULSIS-1 in INPULSIS-2
INPULSIS-1 and INPULSIS-2
INPULSIS-1 in INPULSIS-2 združeno
INR (international normalised ratio) monitoring recommended.
Priporočeno je spremljanje INR (mednarodno normalizirano razmerje).
INR (international normalised ratio) monitoring recommended.
Priporočljivo je spremljanje INR (internacionalnega normaliziranega razmerja).
INR and Factor VII activity were also not affected by the co- administration of febuxostat.
Tudi INR in aktivnost faktorja VII se nista spremenili pri sočasnem dajanju febuksostata
INR and Factor VII activity were also not affected by the co- administration of febuxostat.
Tudi INR in aktivnost faktorja VII se nista spremenili pri sočasnem dajanju febuksostata.
INR increased**
povečana vrednost INR
INR increasedd
Povečan INRd
INR values in case of vitamin K antagonist therapy as per clinical AF guidelines.
Vrednosti INR v primeru zdravljenja z antagonisti vitamina K v skladu s kliničnimi smernicami za AF.
INR values should not be used as they are not a dependable measure of the anticoagulant activity of Xarelto.
Določanje vrednosti INR ni ustrezno merilo za merjenje antikoagulacijskega učinka zdravila Xarelto, zato ga ne uporabljajte.
INR ≤ 1.3 for vitamin K antagonists or other relevant test(s) for other oral anticoagulants are within the respective upper limit of normal).
INR ≤ 1,3 za antagoniste vitamina K ali ko so izvidi drugega ali drugih preizkusov za druge peroralne antikoagulante znotraj območja ustreznih zgornjih normalnih vrednosti).
Insects do not have to ingest dinotefuran.
Insektom ni potrebno zaužiti dinotefurana.
INSERT
VSTAVITE
Insert a 20 G plastic cannula in a large antecubital vein, preferably of the right arm.
Vstavite 20 G plastično kanilo v veliko antekubitalno veno, po možnosti desne roke.
Insert a NovoRapid PumpCart in the cartridge compartment of the pump.
Vstavite vložek NovoRapid PumpCart v razdelek za vložek v insulinski črpalki.
Insert adaptor into the neck of the bottle until a tight seal is made
V vrat plastenke vstavite nastavek, ki plastenko neprepustno zatesni.
Insert and advance the needle transversely through the width of the plaque, towards the opposite side of the plaque without passing completely through it.
Iglo vstavite in potiskajte prečno skozi širino plaka, proti nasprotni strani plaka, a je ne potisnite do konca skozi plak.
Insert capsule:
Vstavite kapsulo:
Insert cartridge into the cartridge holder, then screw the cartridge holder back onto the pen. (Be careful not to touch the rubber seal.)
Vstavite vložek v držalo vložka in držalo vložka privijte nazaj na injekcijski peresnik. (Pazite, da se ne dotaknete gumijaste zapore.)
Insert needle
Zabodite iglo
Insert needle completely to the wings of the needle with a rapid motion straight into the skin at a 90-degree angle.
Na komplet injekcijske igle namestite cevje črpalke ali večjo brizgo s humanim polispecifičnim imunoglobulinom 10 %.
Insert needle directly into the pen cover.
Iglo vstavite v pokrovček napolnjenega injekcijskega
Insert needle into skin using injection technique recommended by your healthcare professional.
Vbodite iglo v kožo z uporabo tehnik injiciranja, ki jih priporoča vaše zdravstveno osebje.
INSERT needle into skin.
ZABODITE iglo v kožo.
Insert needle into the vial through the centre of the stopper and direct the stream of liquid to the wall of the vial to avoid excessive foaming.
Injekcijsko iglo zabodite skozi osrednji del zamaška viale in tok tekočine usmerite na steno viale, da preprečite prekomerno penjenje.
Insert pump into vial
Vstavite razpršilnik v vialo
Insert the applicator (C) firmly into the adapter.
aplikator (C) trdno vstavite v nastavek.
Insert the cartridge into SurePal 10 following the instructions for use provided with the pen.
Vložek vstavite v injekcijski peresnik SurePal 10 po priloženih navodilih za uporabo.
Insert the cartridge into SurePal 15 following the instructions for use provided with the pen.
Vložek vstavite v injekcijski peresnik SurePal 15 po priloženih navodilih za uporabo.
Insert the cartridge into SurePal 5 following the instructions for use provided with the pen.
Vložek vstavite v injekcijski peresnik SurePal 5 po priloženih navodilih za uporabo.
Insert the cartridge into the Omnitrope Pen 10 following the instructions for use provided with the pen.
Vložek vstavite v injekcijski peresnik Omnitrope Pen 10 po priloženih navodilih za uporabo.
Insert the cartridge into the Omnitrope Pen 5 following the instructions for use provided with the pen.
Vložek vstavite v injekcijski peresnik Omnitrope Pen 5 po priloženih navodilih za uporabo.
Insert the entire needle at an angle of 90 degrees into the fold of the skin
Vbodite celotno iglo v kožno gubo pod kotom 90 stopinj.
Insert the full length of the needle into the skin fold
Celotno dolžino igle zabodite v kožno gubo.
Insert the injection needle with a quick dart-like thrust at right angles to the skin, into the muscle.
Vbodite injekcijsko iglo s hitrim sunkom pod pravim kotom na kožo, v mišico.
Insert the injection needle with a quick dart-like thrust at right angles to the skin, into the muscle.
Vbodite injekcijsko igro s hitrim sunkom pod pravim kotom na kožo, v mišico.
Insert the needle all the way into the pinched skin at an angle of 45 to 90 (6).
Iglo pod kotom 45 do 90 do konca potisnite v kožno gubo (6).
Insert the needle as instructed.
Vbodite iglo v kožo v skladu z navodili.
Insert the needle in the ampoule of solvent and withdraw the total amount of solvent.
Vstavite iglo v ampulo z vehiklom in posesajte celotno količino vehikla iz nje.
Insert the needle into the pinched skin at an angle of 45 to 90.
Vbodite iglo v kožno gubo pod kotom 45 do 90.
Insert the needle into the pinched skin at an angle of approximately 45°.
Iglo vbodite v kožno gubo pod kotom približno 45.
Insert the needle into the pinched skin at an angle of approximately 45.
Vbodite iglo v kožno gubo pod kotom približno 45.
Insert the needle into the skin as you have been told by your doctor.
Namestite RebiSmart pod pravim kotom (90°) na kožo.
Insert the needle into the skin as you have been told by your doctor.
Zabodite iglo v kožo, kot vas je poučil vaš zdravnik.
Insert the needle into the vial, push the plunger to expel the air.
Vstavite injekcijsko iglo v vialo in potisnite bat, da iztisnite zrak.
Insert the needle into your skin (subcutaneously).
Iglo zapičite v kožo (subkutano).
Insert the needle into your skin and finish your injection.
Izvlecite iglo iz kože.
Insert the needle into your skin as your doctor or nurse has shown you.
Iglo zabodite v kožo, kot sta vam to pokazala zdravnik ali medicinska sestra.
Insert the needle into your skin as your doctor or nurse has shown you.
Zabodite iglo v kožo, kot sta vam pokazala vaš zdravnik ali medicinska sestra.
Insert the needle into your skin.
Iglo zabodite v kožo.
Insert the needle into your skin.
Zabodite iglo v kožo in končajte injiciranje.
Insert the needle of the pre-filled syringe into the cleaned venous port.
Vstavite iglo napolnjene injekcijske brizge v o iš en venski dostop.
Insert the needle perpendicular to the skin, in the region of the deltoid, in a short, quick movement.
Z naglim in kratkim gibom vstavite iglo pravokotno na kožo v področju deltoidne mišice.
Insert the needle straight through the centre of the vial’s rubber stopper into the suspension.
Iglo vstavite neposredno skozi sredino gumijastega zamaška viale v suspenzijo.
Insert the needle through the rubber top of the Pegasys vial (3).
Iglo potisnite skozi pokrov iz gume na viali zdravila Pegasys (3).
Insert the needle to its full depth into the pinched skin.
Zabodite iglo do konca v stisnjeno kožo.
Insert the needle with a quick dart-like motion, straight into the skin fold.
Iglo vstavite naravnost v kožno gubo s hitrim gibom, podobnim metanju pikada.
Insert the spike of the vented pump tubing or spike and venting needle into human normal immunoglobulin 10% vial(s).
V vialo humanega polispecifičnega imunoglobulina 10 % uvedite konico prezračevanega cevja črpalke ali konico in prezračevalno injekcijsko iglo.
Insert the spike through the rubber closure into the vial of Rapilysin 10 U.
V vialo zdravila Rapilysin 10 enot skozi gumijasti pokrov vstavite pripomoček za pripravo.
Insert the spike through the rubber closure into the vial of Rapilysin 10 U.
V vialo zdravila Rapilysin 10 enot skozi gumijasti pokrov vstavite pripomoček za rekonstitucijo.
Insert the syringe adapter into the bottle until it is flush with the top of the bottle.
V steklenico namestite nastavek za odmerno brizgo, tako da je zgornji rob nastavka v isti višini z vrhom steklenice.
Insert the syringe into the adapter
V adapter vstavite brizgo.
Insert the syringe into the PIBA and draw out the required volume from the inverted bottle (Figures 3 and 4).
Vstavite brizgo v nastavek za peroralno brizgo in odvzemite potreben volumen zdravila iz obrnjene plastenke (Sliki 3 in 4).
Insert the syringe into your baby’s mouth and place it against the inside of the cheek.
Vstavite brizgo v dojenčkova usta in jo pritisnite ob notranji del lica.
Insert the syringe tip into the hole in the bottle lid.
Vrh brizge vstavite v odprtino v zaporki plastenke.
Insert the syringe tip into the horse’s mouth at the interdental space and deposit the paste on the base of the tongue.
Konico brizge vtaknite konju v medzobni prostor v ustih in stisnite pasto na bazo jezika.
Insert the tip of the syringe into the hole in the lid of the mixing bottle.
Vrh brizge vstavite v odprtino v zaporki mešalne plastenke.
Insert the trocar provided with the bag of diluent through the closures of both the glass vial and the diluent bag to connect them.
Trokar, ki je priložen vrečki z vehikelom , potisnite skozi pokrovčka obeh, viale s suspenzijo in vrečke z vehikelom da ju povežete.
Insert the trocar provided with the bag of diluent through the closures of both the glass vial and the diluent bag to connect them.
Trokar, ki je priložen vrečki z vehiklom , potisnite skozi pokrovčka obeh, steklene viale s suspenzijo in vrečke z vehiklom, da ju povežete.
Inserting the needle
Vbod igle
Insertion of a flexible in-dwelling venous catheter is recommended, see section 4.4.
Priporoča se vstavitev prožnega stalnega venskega katetra, glejte poglavje 4.4.
Inside the back cover there’s a fold-out chart with everything you need to make injections with your Avonex Pen.
Znotraj hrbtne platnice je zložljiva tabela z vsem, kar potrebujete, da s svojim napolnjenim injekcijskim peresnikom Avonex Pen izvedete injiciranje.
Inside your pack of STAYVEER tablets you will find a Patient Alert Card which you should read carefully.
Skrbno preberite Opozorilno kartico za bolnika, ki je v škatli s tabletami zdravila.
Inside your pack of STAYVEER tablets you will find a Patient Alert Card.
Znotraj škatle s tabletami STAYVEER je Opozorilna kartica za bolnika.
Inside your pack of Tracleer tablets you will find a Patient Alert Card which you should read carefully.
Skrbno preberite Opozorilno kartico za bolnika, ki je v škatli s tabletami zdravila.
Inside your pack of Tracleer tablets you will find a Patient Alert Card.
Znotraj škatle s tabletami Tracleer je Opozorilna kartica za bolnika.
Insomnia
insomnija
Insomnia
nespečnost,
insomnia
nespečnost;
Insomnia
Svefnleysi
insomnia (difficulty in sleeping)
nespečnost (težave s spanjem)
insomnia (difficulty in sleeping); anxiety; confusion
nespečnost (težave s spanjem), tesnoba, zmedenost
Insomnia (difficulty sleeping)
nespečnost (težave pri spanju),
insomnia (difficulty sleeping)
nespečnost,
insomnia (difficulty sleeping), abnormal dreams, somnolence (sleepiness)
insomnija (nespečnost), neobičajne sanje, somnolenca (bolezenska zaspanost)
insomnia (difficulty sleeping), somnolence (sleepiness), abnormal thinking
insomnija (nespečnost), somnolenca (zaspanost), nenormalno mišljenje,
Insomnia (sleeping difficulty)
nespečnost (težave s spanjem)
insomnia (sleeplessness), drowsiness; ataxia (inability to coordinate muscle movements), hypotonia (low muscle strength), dystonia (involuntary muscle contractions).
insomnija (nespečnost), zaspanost; ataksija (nezmožnost usklajenega gibanja mišic), hipotonija (zmanjšana moč mišičja), distonija (nehoteni mišični krči).
Insomnia Agitation Anxiety Restlessness
nespečnost agitacija tesnoba nemir
Insomnia Anxiety
insomnija tesnoba
Insomnia Anxiety
nespečnost anksioznost nemir
Insomnia Anxiety Irritability Depression Sleep disorder
nespečnost tesnoba razdražljivost depresija motnje spanja
Insomnia Anxiety Restlessness
nespečnost anksioznost
Insomnia Anxiety Restlessness
nespečnost anksioznost nemir
Insomnia Anxiety Restlessness
nespečnost tesnoba nemir
Insomnia Depression
nespečnost depresija
Insomnia Depression Hallucinations
halucinacije
Insomnia Hyperactivity disorder Libido changes
hiperaktivne motnje spremembe v libidu